Sign Up to like & get
recommendations!
0
Published in 2021 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2021.10.138
Abstract: AIM To analyze the prevalence and clinical implications of the eligibility criteria for prolonged dual antithrombotic therapy with ticagrelor 60 mg twice daily and/or rivaroxaban 2.5 mg twice daily in a contemporary real-world ACS registry. METHODS Patients…
read more here.
Keywords:
dual antithrombotic;
eligibility criteria;
eligibility;
therapy ... See more keywords